This is amplified by the fact that anti-TNF treatment improves insulin resistance and increases the levels or atheroprotective HDL, however, it does not seem to ameliorate the overall atherogenic index in the long term, while anti-IL6 treatment seems to improve insulin resistance but increases levels of total cholesterols, LDL, and triglycerides [89,192]. Here, IL6 is linked to Insulin resistance.